{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T23:01:15Z","timestamp":1700002875553},"reference-count":10,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.eimc.2008.05.002","type":"journal-article","created":{"date-parts":[[2009,9,23]],"date-time":"2009-09-23T21:01:54Z","timestamp":1253739714000},"page":"28-32","source":"Crossref","is-referenced-by-count":3,"title":["Fosamprenavir (GW433908)\/ritonavir in HIV-infected patients: efficacy and safety results from the Spanish Expanded Access Program"],"prefix":"10.1016","volume":"27","author":[{"given":"M. Jes\u00fas","family":"P\u00e9rez-Elias","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"S\u00e1nchez-Conde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicente","family":"Soriano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josep","family":"Mallolas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Luque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felipe","family":"Rodr\u00edguez-Alc\u00e1ntara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eimc.2008.05.002_bib1","first-page":"22","article-title":"Decline in the AIDS and death rates in the EuroSIDA study","volume":"362","author":"Mocroft","year":"2003","journal-title":"An observational study. Lancet."},{"key":"10.1016\/j.eimc.2008.05.002_bib2","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1086\/500210","article-title":"Effect of maintaining highly active antiretroviral therapy on AIDS events among patients with late-stage HIV infection and inadequate response to therapy","volume":"42","author":"Gandhi","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2008.05.002_bib3","series-title":"Guidelines for the Use of Antiretroviral Agents in HIV-1 infected Adults and Adolescents","year":"2008"},{"key":"10.1016\/j.eimc.2008.05.002_bib4","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1157\/13096750","article-title":"Recomendaciones de GESIDA\/Plan Nacional sobre el SIDA respecto al tratamiento antiretroviral en pacientes adultos infectados por el virus de la inmunodeficiencia humana (actualizaci\u00f3n Enero de 2007)","volume":"25","year":"2007","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.eimc.2008.05.002_bib5","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1097\/01.aids.0000131332.30548.92","article-title":"SOLO: 48-week efficacy and safety comparison of once-daily fosamprenavir\/ritonavir versus twice-daily nelfinavir in na\u00efve HIV-1 infected patients","volume":"18","author":"Gathe","year":"2004","journal-title":"AIDS"},{"key":"10.1016\/j.eimc.2008.05.002_bib6","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0140-6736(06)69155-1","article-title":"The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised non-inferiority trial","volume":"368","author":"Eron","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.eimc.2008.05.002_bib7","doi-asserted-by":"crossref","unstructured":"De Jesus E, La Marca A, Sension M, et al. The CONTEXT study: efficacy and safety of GW433908\/RTV in PI-experienced patients with virological failure (24 weeks results) [abstract]. 10th Conference on Retroviruses and opportunistic Infections; 2003 Feb 10-14; Boston.","DOI":"10.2165\/00128413-200313780-00026"},{"key":"10.1016\/j.eimc.2008.05.002_bib8","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.clinthera.2006.05.011","article-title":"Long-term (120-week) antiviral efficacy and tolerability of fosamprenavir\/ritonavir once daily in therapy-naive patients with hiv-1 infection: an uncontrolled, open-label, single-arm follow-on study","volume":"28","author":"Gathe","year":"2006","journal-title":"Clin Ther"},{"key":"10.1016\/j.eimc.2008.05.002_bib9","unstructured":"Telzir\u00ae Product Information, European Medicine Agency, version 18\/04\/2006. Available from: http:\/\/www.emea.eu.int\/humandocs\/Humans\/EPAR\/telzir\/telzir.htm."},{"key":"10.1016\/j.eimc.2008.05.002_bib10","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1086\/380509","article-title":"Incidence of resistance in a double-blind study comparing lopinavir\/ritonavir plus stavudine and lamivudine to nelfinavir plus stavudine and lamivudine","volume":"189","author":"Kempf","year":"2004","journal-title":"J Infect Dis"}],"container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X08000049?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X08000049?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T20:21:42Z","timestamp":1558556502000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213005X08000049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S0213005X08000049"],"URL":"https:\/\/doi.org\/10.1016\/j.eimc.2008.05.002","relation":{},"ISSN":["0213-005X"],"issn-type":[{"value":"0213-005X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}